Scinovex
article Open AccessTop 1% cited

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

New England Journal of Medicine · 2001 · Vol. 345(12) · pp. 861–869
Barry M. BrennerMark E. CooperDick de ZeeuwWilliam F. KeaneWilliam E. MitchHans‐Henrik ParvingGiuseppe RemuzziSteven SnapinnZhonxin ZhangShahnaz Shahinfar

Abstract

Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.

Blood Pressure and Hypertension StudiesRenin-Angiotensin System StudiesChronic Kidney Disease and DiabetesMedicineLosartanInternal medicineDiabetic nephropathyNephropathyDiabetes mellitusType 2 diabetesCreatinineKidney diseaseBlood pressure

MeSH terms

AdultAgedAntihypertensive AgentsCardiovascular DiseasesCreatineCreatinineDiabetes Mellitus, Type 2Diabetic NephropathiesDouble-Blind MethodFemaleHumansHypertensionKidney Failure, ChronicMaleMiddle Aged
Citations
7,433
FWCI
231.98
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
References
A Multiple Testing Procedure for Clinical Trials
Biometrics · 1979 · 3,326 citations
A simplified equation to predict glomerular filtration rate from serum creatinine
Journal of the American Society of Nephrology · 2000 · 1,724 citations
Nonparametric Estimation from Incomplete Observations
Journal of the American Statistical Association · 1958 · 7,746 citations
Regression Models and Life-Tables
Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 38,926 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.